Scholars Central

Conference abstractPublished 2019

Early identification and efficient therapy of neurodegenerative disorders: Nanotechnology as a tool

Authors: Jerzy Leszek

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Alzheimer’s Disease (AD) is most common cause of dementia among people of aged 65 and older. The diagnosis of sporadic AD is based on clinical exclusion criteria and is only definite at necropsy. So, biochemical markers for AD would be of great value for its early diagnosis. During the last decade, research efforts have focused on developing CSF biomarkers for AD. The diagnosis performance of the CSF biomarkers: Tau protein, the 42-amino acid form of beta amyloid (ABeta 42) and amyloid precursor protein are of great importance. Since AD pathology is irreversible and present-day medications for AD only lower its associated symptoms, application of disease-modifying treatments could be successful only if AD early diagnosis is possible. The recently growing application of nanotechnology in molecular detection of biomarkers is promising for very early diagnosis of AD. From a practical point of view, one may perform a molecular detection process either inside the body (in vivo) or on the samples derived from the body (in vitro). In his presentation, author discuss the challenges of current treatment and diagnosis of AD and the development of biocompatible nanoparticles- provide the rational and potentials using nanoparticles for both drug carrier and imaging contrast agent for early diagnosis and treatment of AD and other neurodegenerative disorders like Parkinson Disease.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Neuroscience and Neuropharmacology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Neuroscience and Neuropharmacology
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Jerzy Leszek”